Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Drug Giant Fined for Marketing Risperdal as a Dementia Treatment

Posted Nov 13 2013 12:00am
Again, the big pharmaceuticals demonstrate their desire for big profits over good
medicine.
My late father was given drugs that I found were clearly stated (on-line) to be contraindicated for patients with dementia. I would blame his LTC physician's ignorance, which I later reported, but also the lobbying by drug companies to market their drugs.
The system isn't broken, just abused - horribly, by either ignorant physicians, or those who are ignoring current practices.

The pharma business in the US has been demonstrated to be corrupt, time and time again. Excellent post on AgingCare.com
Drug Giant Fined for Marketing Risperdal as a Dementia Treatment By 

Big bucks in Rx
In one of the largest health care fraud settlements in U.S. history, pharmaceutical titan Johnson & Johnson (J&J) will shell out $1.7 billion to resolve legal claims surrounding one of its most popular antipsychotics, Risperdal. The company faces criminal and civil allegations that it—via subsidiary, Janssen Pharmaceuticals—inappropriately marketed Risperdal as a way to manage anxiety and other psychological symptoms in people with dementia.
Post a comment
Write a comment:

Related Searches